Imunon, Inc.
IMNN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15 | $18 | $18 | $16 |
| - Cash | $0 | $5 | $3 | $6 |
| + Debt | $1,102 | $1 | $1 | $1 |
| Enterprise Value | $1,117 | $14 | $16 | $11 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$2 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$3 | -$4 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$3 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.16 | -1.87 | -3.676 | -3.65 |
| % Growth | 38% | 49.1% | -0.7% | – |
| Operating Cash Flow | -$4 | -$3 | -$3 | -$4 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$3 | -$3 | -$4 |